As a cancer biologist, these insights highlight the potential of CHAC1 as a biomarker and therapeutic target, paving the way for novel strategies to manage oxidative stress-related pathologies and enhance the efficacy of cancer treatments
Succinate metabolism: a promising therapeutic target for inflammation, ischemia/reperfusion injury and cancer
Youll usually stay on this dose for at least 4 weeks before moving to 7.5 mg, depending on how you feel and your clinicians advice
However, GLP-1 drugs have surged in popularity due to their ability to support major weight loss and reduce risks for chronic conditions, including heart disease
ADs are becoming more prevalent in developed countries of the western world, with environmental factors, specifically dietary components, thought to be major contributing factors (Parks et al
Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy